CRISPR Therapeutics (NASDAQ: CRSP) is a clinical-stage biotechnology company founded in 2013 and headquartered in Zug, Switzerland, with US operations in Boston, Massachusetts. Co-founded by CRISPR/Cas9 pioneer Emmanuelle Charpentier, the company develops transformative gene-based medicines for serious human diseases. - View it on GitHub